AMSTERDAM, The Netherlands, May 15, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, today announced that the Board of Directors of Eurand N.V. will convene an Annual General Meeting (“AGM”) of the Company’s shareholders on Friday, May 30, 2008 at 10:00AM (CET). The meeting will be held at Eurand’s offices in Amsterdam, The Netherlands located at Fred Roeskestraat 123, 1076 EE Amsterdam, The Netherlands.
